S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

Diurnal Group (DNL) Share Forecast, Price & News

GBX 12.75
0.00 (0.00%)
(As of 05/13/2022 03:58 PM ET)
Today's Range
50-Day Range
52-Week Range
235,244 shs
Average Volume
469,694 shs
Market Capitalization
£21.64 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive DNL News and Ratings via Email

Sign-up to receive the latest news and ratings for Diurnal Group and its competitors with MarketBeat's FREE daily newsletter.

Diurnal Group logo

About Diurnal Group

Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers an oral formulation of hydrocortisone granules in capsules for the treatment of pediatric adrenal insufficiency. It also develops Chronocort, which completed Phase II clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early-stage pipeline products comprise Ditest, a native oral testosterone product, which has completed phase I clinical trial for the treatment of classical hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (triiodothyronine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Specialty & Generic
Year Founded

Sales & Book Value

Annual Sales
£5.28 million
Cash Flow
GBX 14.40 per share
Book Value
GBX 17.70 per share


Pretax Margin




Free Float
Market Cap
£21.64 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

1.42 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Diurnal Group (LON:DNL) Frequently Asked Questions

How were Diurnal Group's earnings last quarter?

Diurnal Group plc (LON:DNL) issued its quarterly earnings data on Tuesday, September, 15th. The company reported ($4.30) EPS for the quarter, topping analysts' consensus estimates of ($6.70) by $2.40.
View Diurnal Group's earnings history

Who are Diurnal Group's key executives?
Diurnal Group's management team includes the following people:
  • Mr. Richard Edward Bungay A.C.A., ACA, B.Sc., BSc, Interim CEO, CFO, Company Sec. & Director (Age 53, Pay $338k)
  • Prof. Richard Ross, Chief Scientific Officer & Exec. Director
  • Mr. Stewart Jones, Operations Director
  • Mr. John Porter MBBS, Ph.D., Chief Medical Officer
  • Mr. David Bevan, Chief Bus. Officer (Age 55)
What other stocks do shareholders of Diurnal Group own?
What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 12.75.

How much money does Diurnal Group make?

Diurnal Group has a market capitalization of £21.64 million and generates £5.28 million in revenue each year.

How many employees does Diurnal Group have?

Diurnal Group employs 33 workers across the globe.

What is Diurnal Group's official website?

The official website for Diurnal Group is www.diurnal.co.uk.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.